Follow
Monika Hegi
Monika Hegi
Full Professor, Lausanne University Hospital, Switzerland
Verified email at chuv.ch
Title
Cited by
Cited by
Year
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
ME Hegi, AC Diserens, T Gorlia, MF Hamou, N De Tribolet, M Weller, ...
New England Journal of Medicine 352 (10), 997-1003, 2005
84152005
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the …
R Stupp, ME Hegi, WP Mason, MJ Van Den Bent, MJB Taphoorn, ...
The lancet oncology 10 (5), 459-466, 2009
81032009
Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial
R Stupp, S Taillibert, A Kanner, W Read, DM Steinberg, B Lhermitte, ...
Jama 318 (23), 2306-2316, 2017
21072017
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
A Malmström, BH Grønberg, C Marosi, R Stupp, D Frappaz, H Schultz, ...
The lancet oncology 13 (9), 916-926, 2012
1436*2012
Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial
R Stupp, S Taillibert, AA Kanner, S Kesari, DM Steinberg, SA Toms, ...
Jama 314 (23), 2535-2543, 2015
12792015
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
M Weller, M van den Bent, M Preusser, E Le Rhun, JC Tonn, G Minniti, ...
Nature reviews Clinical oncology 18 (3), 170-186, 2021
11302021
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial
MR Gilbert, M Wang, KD Aldape, R Stupp, ME Hegi, KA Jaeckle, ...
Journal of clinical oncology 31 (32), 4085, 2013
10582013
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre …
R Stupp, ME Hegi, T Gorlia, SC Erridge, J Perry, YK Hong, KD Aldape, ...
The lancet oncology 15 (10), 1100-1108, 2014
10222014
Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
ME Hegi, L Liu, JG Herman, R Stupp, W Wick, M Weller, MP Mehta, ...
Journal of clinical oncology 26 (25), 4189-4199, 2008
10202008
European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Effects of …
R Stupp, ME Hegi, WP Mason, MJ van den Bent, MJ Taphoorn, ...
Lancet Oncol 10 (5), 459-466, 2009
10142009
Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide
ME Hegi, AC Diserens, S Godard, PY Dietrich, L Regli, S Ostermann, ...
Clinical cancer research 10 (6), 1871-1874, 2004
9982004
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
M Weller, M Van Den Bent, JC Tonn, R Stupp, M Preusser, ...
The lancet oncology 18 (6), e315-e329, 2017
9972017
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
M Weller, R Stupp, G Reifenberger, AA Brandes, MJ Van Den Bent, ...
Nature Reviews Neurology 6 (1), 39-51, 2010
8522010
Stem cell–related “self-renewal” signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma
A Murat, E Migliavacca, T Gorlia, WL Lambiv, T Shay, MF Hamou, ...
Journal of clinical oncology 26 (18), 3015-3024, 2008
8142008
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
PY Wen, M Weller, EQ Lee, BM Alexander, JS Barnholtz-Sloan, ...
Neuro-oncology 22 (8), 1073-1113, 2020
7182020
Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22
LA Cannon-Albright, DE Goldgar, LJ Meyer, CM Lewis, DE Anderson, ...
Science 258 (5085), 1148-1152, 1992
7061992
Chemoradiotherapy in malignant glioma: standard of care and future directions
R Stupp, ME Hegi, MR Gilbert, A Chakravarti
Journal of Clinical Oncology 25 (26), 4127-4136, 2007
6642007
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE. 3
T Gorlia, MJ van den Bent, ME Hegi, RO Mirimanoff, M Weller, ...
The lancet oncology 9 (1), 29-38, 2008
6382008
Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells
F Klemm, RR Maas, RL Bowman, M Kornete, K Soukup, S Nassiri, ...
Cell 181 (7), 1643-1660. e17, 2020
6352020
In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice.
M Harvey, AT Sands, RS Weiss, ME Hegi, RW Wiseman, P Pantazis, ...
Oncogene 8 (9), 2457-2467, 1993
6271993
The system can't perform the operation now. Try again later.
Articles 1–20